• Y-mAbs Therapeutics' (YMAB) "Outperform" Rating Reaffirmed at Wedbush

    Source: Buzz FX / 04 Mar 2025 17:51:14   America/Chicago


    Y-mAbs Therapeutics' (YMAB) "Outperform" Rating Reaffirmed at Wedbush Written by MarketBeat March 4, 2025 Share Link copied to clipboard. Y-mAbs Therapeutics ( NASDAQ:YMAB - Get Free Report ) 's stock had its "outperform" rating reaffirmed
    Read more...
Share on,